← All indications
Vaginitis
Inflammation of the vagina characterized by pain and a purulent discharge.
Subtype terms (4)
More specific conditions that are subtypes of Vaginitis in the MeSH hierarchy.
- Atrophic Vaginitis
19 drugs (7 approved, 12 experimental)
- Trichomonas Vaginitis
12 drugs (6 approved, 6 experimental)
- Vaginosis, Bacterial
79 drugs (36 approved, 43 experimental)
- Vulvovaginitis
10 drugs (8 approved, 2 experimental)
Drugs by status
Approved for this indication (4)
Phase 4 trials (13)
Phase 3 trials (11)
Phase 2 trials (3)
Phase 1 trials (2)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (17)
- Novo Nordisk
- Laboratoire Innotech International
- Shaanxi Buchang Pharmaceutical Co., Ltd
- National Institute on Aging (NIA)
- AGUNCO Obstetrics and Gynecology Centre
- National Cheng Kung University
- University of Louisville
- Peking University
- University of Sarajevo
- University of Alabama, Birmingham
- Universidade Federal do Parana
- MonitorCRO
- Fournier Labs
- Yeshiva University
- Exeltis
- Beijing Compete Pharmaceutical Co., Ltd.
- University of Tuzla
Organization Involved with Phase 3 Indications (36)
- Actavis
- Lumara Health
- Pfizer
- Mylan
- Wyeth
- Alvogen
- National Institute of Allergy and Infectious Diseases (NIAID)
- University of London
- Johns Hopkins University
- Tulane University
- Mayo Clinic
- Assiut University
- Amneal Pharmaceuticals
- Health Awareness, Inc
- Novum Pharmaceutical Research Services
- Comprehensive Clinical Trials, LLC
- Meridien Research
- Visions Clinical Research
- Horizons Clinical Research Center, LLC
- Lawrence OB/GYN Clinical Research, LLC
- Physician Care Clinical Research LLC
- Veritas Research., Corp.
- South Coast Research Center, Inc.
- OB-GYN Associates of Mid Florida
- MCB Clinical Research Centers, LLC
- Sunrise Medical Research, Inc.
- Arizona Research Associates
- AXIS Clinicals Limited
- University of Insubria
- University of Sherbrooke
- +6 more
Organization Involved with Phase 2 Indications (25)
- CONRAD
- Embil Pharmaceutical Co. Ltd
- Izun Pharma Ltd
- Population Council
- FHI 360
- Medical Research Council, South Africa
- Brown University
- Eastern Virginia Medical School
- Northwell Health
- Ohio State University
- University of Limpopo
- University of Toronto
- University of Vermont
- University of Cape Town
- Icahn School of Medicine at Mount Sinai
- Hofstra University
- Cidara Therapeutics
- University of North Carolina at Chapel Hill
- Bill and Melinda Gates Foundation
- Chiangrai Prachanukroh Hospital
- United States Agency for International Development
- Chiang Rai District Health Office
- National Center for Infectious Diseases
- Government of Thailand
- Centers for Disease Control and Prevention (CDC)
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (9)